meRfi®-GM
Anaerobutyricum hallii
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
In humans, it was established in a 2021 paper that a single duodenal dose of A. soehngenii increased levels of GLP1 and of serum secondary bile salts in 12 individuals with metabolic syndrome , thereby potentially explaining the observed improvements in glucose metabolism
Some microbes, such as Eubacterium hallii, can produce [butyrate](brain://E42jsss5J0Kk0Df0…
References (Sources)
- Duodenal Anaerobutyricum soehngenii infusion stimulates GLP-1 production, ameliorates glycaemic control and beneficially shapes the duodenal transcriptome in metabolic syndrome subjects: a randomised double-blind placebo-controlled cross-over study
- Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers
- From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
- Towards the human intestinal microbiota phylogenetic core